Search Clinical Trials
589,776 trials
ID
Status
Phase
Title
Sponsor
NCT07655037
Execise Intervention in Adult Severe AsthmaHelsinki University Central HospitalRecruitingNot Applicable
NCT07655037Recruiting
Not Applicable
Execise Intervention in Adult Severe AsthmaHelsinki University Centr...
NCT07653191
Changes in Uterine Artery Resistance Index Following Cervical ConizationAdana City Training and Research HospitalCompletedNot Applicable
NCT07653191Completed
Not Applicable
Changes in Uterine Artery Resistance Index Following Cervical ConizationAdana City Training and R...
NCT07652476
Neurocognitive Assessment in Long-Term Survivors of LymphomaAssociazione Italiana contro Leucemie, Linfomi e MielomaNot Yet Recruiting
NCT07652476Not Yet Recruiting
—
Neurocognitive Assessment in Long-Term Survivors of LymphomaAssociazione Italiana con...
NCT07653828
Evaluation of the Impact of Self-rehabilitation After Foot Surgery Via a Connected ApplicationRamsay Générale de SantéRecruitingNot Applicable
NCT07653828Recruiting
Not Applicable
Evaluation of the Impact of Self-rehabilitation After Foot Surgery Via a Connect...Ramsay Générale de Santé
NCT07653659
Hemodynamic Effects of Norepinephrine Reduction on Critical Closing Pressure in Distributive ShockPeking Union Medical College HospitalRecruiting
NCT07653659Recruiting
—
Hemodynamic Effects of Norepinephrine Reduction on Critical Closing Pressure in...Peking Union Medical Coll...
NCT07655115
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With thFundación para la Investigación Biomédica del Hospital Gregorio MaranonRecruitingPhase 3
NCT07655115Recruiting
Phase 3
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability...Fundación para la Investi...
NCT07654231
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD: A Pilot Randomized Open-Label TrialUniversity of Texas Southwestern Medical CenterNot Yet RecruitingPhase 2
NCT07654231Not Yet Recruiting
Phase 2
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchi...University of Texas South...
NCT07654647
Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction.Tishreen UniversityRecruitingNot Applicable
NCT07654647Recruiting
Not Applicable
Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial...Tishreen University
NCT07654621
Combined Manual Therapy and Percutaneous Neuromodulation for Moderate Carpal Tunnel SyndromeUniversidad Europea de ValenciaNot Yet RecruitingNot Applicable
NCT07654621Not Yet Recruiting
Not Applicable
Combined Manual Therapy and Percutaneous Neuromodulation for Moderate Carpal Tun...Universidad Europea de Va...
NCT07654244
Cerebral Near-infrared Spectroscopy in Patients Undergoing Open Cardiovascular Surgery Using Artificial Intelligence Programs: A Methodological StudyAntalya Health Sciences UniversityNot Yet Recruiting
NCT07654244Not Yet Recruiting
—
Cerebral Near-infrared Spectroscopy in Patients Undergoing Open Cardiovascular S...Antalya Health Sciences U...
NCT07654816
THE EFFECT OF EDUCATION PROVIDED TO ADOLESCENTS LIVING IN A CONTAINER SETTLEMENT ON THEIR GENITAL HYGIENE BEHAVIOURS AND MENSTRUAL EXPERIENCESKahramanmaras Sutcu Imam UniversityCompletedNot Applicable
NCT07654816Completed
Not Applicable
THE EFFECT OF EDUCATION PROVIDED TO ADOLESCENTS LIVING IN A CONTAINER SETTLEMENT...Kahramanmaras Sutcu Imam...
NCT07653386
Clinical Trial of an Ointment in Patients With Mild and Moderate Atopic DermatitisVinUniversityCompletedNot Applicable
NCT07653386Completed
Not Applicable
Clinical Trial of an Ointment in Patients With Mild and Moderate Atopic Dermatit...VinUniversity
NCT07655440
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)Stanford UniversityNot Yet RecruitingPhase 4
NCT07655440Not Yet Recruiting
Phase 4
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in...Stanford University
NCT07653425
Traditional Versus Cluster Resistance Training in Striking Combat Sport AthletesUniversidad de GranadaCompletedNot Applicable
NCT07653425Completed
Not Applicable
Traditional Versus Cluster Resistance Training in Striking Combat Sport AthletesUniversidad de Granada
NCT07653477
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)The United Bio-Technology (Hengqin) Co., Ltd.Not Yet RecruitingPhase 3
NCT07653477Not Yet Recruiting
Phase 3
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadeq...The United Bio-Technology...
NCT07653074
Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among YouthGöteborg UniversityRecruiting
NCT07653074Recruiting
—
Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myo...Göteborg University
NCT07652892
Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRecruiting
NCT07652892Recruiting
—
Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD)...Fundació Institut de Rece...
NCT07654322
Clinical Study on the Efficacy of Laparoscopic Assisted Open Surgery Through Subclavian Approach for Unilateral Thyroid CancerXijing HospitalNot Yet Recruiting
NCT07654322Not Yet Recruiting
—
Clinical Study on the Efficacy of Laparoscopic Assisted Open Surgery Through Sub...Xijing Hospital
Result Breakdown
Recruiting7 (35%)
Not yet recruiting7 (35%)
Completed4 (20%)
Enrolling by invitation1 (5%)
Unknown1 (5%)
Not Specified8 (40%)
not_applicable8 (40%)
Phase 32 (10%)
Phase 21 (5%)
Phase 41 (5%)